
Syed Taha Iqbal
Examiner (ID: 5838, Phone: (571)270-5857 , Office: P/1736 )
| Most Active Art Unit | 1736 |
| Art Unit(s) | 1793, 1736 |
| Total Applications | 941 |
| Issued Applications | 713 |
| Pending Applications | 67 |
| Abandoned Applications | 178 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14132699
[patent_doc_number] => 20190100739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-04
[patent_title] => METHODS FOR THE MANUFACTURE OF PROTEOLYTICALLY PROCESSED POLYPEPTIDES
[patent_app_type] => utility
[patent_app_number] => 16/105120
[patent_app_country] => US
[patent_app_date] => 2018-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18988
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105120
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/105120 | Methods for the manufacture of proteolytically processed polypeptides | Aug 19, 2018 | Issued |
Array
(
[id] => 16771103
[patent_doc_number] => 10982198
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Compositions and methods relating to a mutant
[patent_app_type] => utility
[patent_app_number] => 16/104938
[patent_app_country] => US
[patent_app_date] => 2018-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 63
[patent_no_of_words] => 67070
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16104938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/104938 | Compositions and methods relating to a mutant | Aug 18, 2018 | Issued |
Array
(
[id] => 16451074
[patent_doc_number] => 20200360500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/638846
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638846 | PNEUMOCOCCAL CONJUGATE VACCINE FORMULATIONS | Aug 12, 2018 | Abandoned |
Array
(
[id] => 16459530
[patent_doc_number] => 10842858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Compositions and methods of enhancing immune responses to
[patent_app_type] => utility
[patent_app_number] => 16/028599
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6672
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028599
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/028599 | Compositions and methods of enhancing immune responses to | Jul 5, 2018 | Issued |
Array
(
[id] => 17489300
[patent_doc_number] => 11278581
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Use of vaginal
[patent_app_type] => utility
[patent_app_number] => 16/627248
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11134
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627248
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627248 | Use of vaginal | Jul 4, 2018 | Issued |
Array
(
[id] => 15990473
[patent_doc_number] => 20200171107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS
[patent_app_type] => utility
[patent_app_number] => 16/627118
[patent_app_country] => US
[patent_app_date] => 2018-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/627118 | HIGH POTENCY STABLE FORMULATIONS OF VAGINAL LACTOBACILLUS | Jul 4, 2018 | Abandoned |
Array
(
[id] => 16296314
[patent_doc_number] => 20200282037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => BACTERIAL VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/622900
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -108
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622900
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622900 | BACTERIAL VACCINE | Jun 14, 2018 | Abandoned |
Array
(
[id] => 16009135
[patent_doc_number] => 20200179410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => VITAMIN D COMPOUNDS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/620376
[patent_app_country] => US
[patent_app_date] => 2018-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16620376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/620376 | Vitamin D compounds and methods of using the same | Jun 7, 2018 | Issued |
Array
(
[id] => 16634336
[patent_doc_number] => 10912823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-09
[patent_title] => Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
[patent_app_type] => utility
[patent_app_number] => 15/992627
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7308
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15992627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/992627 | Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin | May 29, 2018 | Issued |
Array
(
[id] => 13593339
[patent_doc_number] => 20180348218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => SEROLOGY ASSAY FOR RECENT MALARIA INFECTION
[patent_app_type] => utility
[patent_app_number] => 15/991355
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5906
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991355
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/991355 | SEROLOGY ASSAY FOR RECENT MALARIA INFECTION | May 28, 2018 | Abandoned |
Array
(
[id] => 13440833
[patent_doc_number] => 20180271959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 15/989742
[patent_app_country] => US
[patent_app_date] => 2018-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15989742
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/989742 | SUSTAINED RELEASE POLOXAMER CONTAINING PHARMACEUTICAL COMPOSITIONS | May 24, 2018 | Abandoned |
Array
(
[id] => 13563849
[patent_doc_number] => 20180333472
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-22
[patent_title] => TREATMENT OF PLANTAR FASCIITIS
[patent_app_type] => utility
[patent_app_number] => 15/978931
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3715
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978931 | TREATMENT OF PLANTAR FASCIITIS | May 13, 2018 | Abandoned |
Array
(
[id] => 13383613
[patent_doc_number] => 20180243348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
[patent_app_type] => utility
[patent_app_number] => 15/964285
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33610
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15964285
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/964285 | Human-derived bacteria that induce proliferation or accumulation of regulatory T cells | Apr 26, 2018 | Issued |
Array
(
[id] => 16762606
[patent_doc_number] => 20210108187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => BOTULINUM NEUROTOXINS PRODUCTION METHODS
[patent_app_type] => utility
[patent_app_number] => 16/608360
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608360 | BOTULINUM NEUROTOXINS PRODUCTION METHODS | Apr 26, 2018 | Abandoned |
Array
(
[id] => 13383735
[patent_doc_number] => 20180243409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => SYNTHETIC CONJUGATE OF CpG DNA AND T-HELP/CTL PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 15/963173
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15963173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/963173 | Synthetic conjugate of CpG DNA and T-help/CTL peptide | Apr 25, 2018 | Issued |
Array
(
[id] => 16491202
[patent_doc_number] => 10857220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Staphylococcal coagulase antigens and methods of their use
[patent_app_type] => utility
[patent_app_number] => 15/962115
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 44662
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15962115
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/962115 | Staphylococcal coagulase antigens and methods of their use | Apr 24, 2018 | Issued |
Array
(
[id] => 16259986
[patent_doc_number] => 10751395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-25
[patent_title] => Method of treating depression
[patent_app_type] => utility
[patent_app_number] => 15/957494
[patent_app_country] => US
[patent_app_date] => 2018-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6016
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15957494
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/957494 | Method of treating depression | Apr 18, 2018 | Issued |
Array
(
[id] => 15130083
[patent_doc_number] => 10478478
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Treatment of Raynaud's phenomenon using botulinum toxin type B
[patent_app_type] => utility
[patent_app_number] => 15/941089
[patent_app_country] => US
[patent_app_date] => 2018-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3071
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15941089
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/941089 | Treatment of Raynaud's phenomenon using botulinum toxin type B | Mar 29, 2018 | Issued |
Array
(
[id] => 15493251
[patent_doc_number] => 20200046814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => BOTULINUM NEUROTOXINS FOR USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/496011
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496011 | Botulinum neurotoxins for use in therapy | Mar 21, 2018 | Issued |
Array
(
[id] => 13462321
[patent_doc_number] => 20180282703
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/925633
[patent_app_country] => US
[patent_app_date] => 2018-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925633
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/925633 | Bacteriophage and antibacterial composition comprising the same | Mar 18, 2018 | Issued |